These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 4382350

  • 1. [Extrapyramidal symptoms during the use of neuroleptics].
    Ditfurth HV.
    Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-acting, antipsychotic agents and extrapyramidal side effects.
    Simpson GM.
    Dis Nerv Syst; 1970 Sep; 31():Suppl:12-4. PubMed ID: 5476354
    [No Abstract] [Full Text] [Related]

  • 6. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM, Tétreault L.
    Rev Can Biol; 1972 Sep; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract] [Full Text] [Related]

  • 7. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale].
    Torrini M, Masini E, Ledda F, Mannaioni PF.
    Clin Ter; 1981 Jun 30; 97(6):561-85. PubMed ID: 7023804
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Symptoms of the extrapyramidal syndrome during maintenence therapy with neuroleptic drugs].
    Sujecka-Szymkiewicz H.
    Psychiatr Pol; 1967 Jun 30; 1(1):79-84. PubMed ID: 4876412
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Koh CV, Ananth JV, Ban TA, Lehmann HE.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr 30; 4(3):289-91. PubMed ID: 4931413
    [No Abstract] [Full Text] [Related]

  • 15. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

  • 16. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M.
    Acta Psychiatr Belg; 1972 Mar 15; 72(2):233-40. PubMed ID: 5056017
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.